Drawing for THERACARE

USPTO serial 85736813

THERACARE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
OH, WON TEAK
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with THERACARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sally M. Abel, Esq.

SALLY M. ABEL, ESQ. FENWICK & WEST LLP801 CALIFORNIA STMOUNTAIN VIEW, CA 94041-1990UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Reagents for scientific or research use; diagnostic reagents for laboratory use, namely, for clinical or medical or forensic laboratory use; chemical preparations for scientific purposes; reagents for chemical analysis; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; testing kits containing reagents used in analyzing and detecting certain toxins for clinical or medical laboratory use; genetic identity tests comprised of reagents; antibodies for in vitro scientific or research use; biochemicals, namely, for in vitro and in vivo scientific use; biomedical compounds, namely, substrates used in analyzing and detecting certain toxins for laboratory or research use; biomedical compounds, namely, substrates used in analyzing and detecting certain toxins for laboratory or research use; chemical preparations to be used in biochemical and clinical research; diagnostic preparations for laboratory use, namely, for clinical or medical or forensic laboratory use; chemically-treated nonmedical test strips for laboratory analysis of blood and other body fluidsACTIVE—
005Biological and chemical preparations for medical or veterinary use for the diagnosis and treatment of a wide variety of hematological, neurological, pulmonary, endocrinal, muscular and cardiac related physical conditions and diseases; reagents and media for medical or veterinary diagnostic purposes; clinical medical reagents; diagnostic biological and chemical preparations, namely, monoclonal antibodies for clinical, medical or veterinary use to detect and analyze substances; diagnostic kits for medical or veterinary use, comprised of medical diagnostic reagents and assays for testing blood and other body fluids; diagnostic preparations for medical or veterinary purposes; testing kits comprised of medical diagnostic reagents and assays for testing of bodily fluids; medical diagnostic test kits comprised of reagents and assays for testing of body fluids; medical diagnostic and monitoring test strips for use in the detection of a wide variety of diseases and health conditions; test strips for medical analysis of blood and other body fluids; ovulation test kits; biological tissue cultures for medical or veterinary purposes; culture media for cultivating blood cells for medical purposesACTIVE—
009Computer software for healthcare monitoring; computer software for medical diagnostics testing and monitoring and for communicating medical test results to patients and service providers in the medical and healthcare fields; computer software for use in biomonitoring of humans and of animals; computer software for medical monitoring and analysis of medical data; computer software for controlling the operation of medical test equipment and test results; computer software for analysis of body fluids; computer software for communication and data transfer between health care professionals and patients; computer hardware; electronic publications, namely, downloadable newsletters, blogs, e-zines, magazines, books, manuals, pamphlets, diaries and journals in the fields of healthcare, medicine, personal health and fitness, biomonitoring, medical diagnostics, monitoring and testingACTIVE—
010Medical devices, namely, portable biomonitoring devices for monitoring blood pressure, pulse, heart rate, respiration, blood oxygen, blood glucose, blood composition, cholesterol, temperature and weight; medical devices, namely, apparatus for laboratory analysis of body fluids and tissue; medical devices, namely, point of care and handheld devices for analysis of drugs, proteins and other substances, and wireless transfer of medical data; medical measuring apparatus, namely, equipment for medical monitoring and analysis of body fluids and tissue; medical measuring apparatus, namely, cartridges containing sensors for measuring and analyzing bodily fluids and pharmaceutical concentrations for use with therapies or equipment for medical monitoring and analysis of substances; apparatus for blood analysis; apparatus for taking blood samples; blood testing apparatus; apparatus for urine analysis for medical diagnostics, monitoring and reporting; general diagnostic and monitoring apparatus for biological tissue or fluid analysis; apparatus for clinical diagnosis; containers especially made for processing blood samples; devices for monitoring blood sugar; health monitoring devices, namely, personal medical monitors of blood pressure, pulse, heart rate, respiration, blood oxygen, blood glucose, blood composition, cholesterol, temperature and weight, for monitoring a wide variety of physical conditions and diseases; medical apparatus and instruments for monitoring blood properties; medical devices for obtaining body fluid samples; medical monitors for monitoring a wide variety of physical conditions and diseases, namely, individualized, electronic monitors for measuring biochemical, hematological, neurological, pulmonary, endocrinal, muscular and cardiac activity; home or portable monitors for monitoring a wide variety of physical conditions and diseases, namely, individualized, electronic monitors for measuring biochemical, hematological, neurological, pulmonary, endocrinal, muscular and cardiac activity; mobile electronic devices, namely, testing, monitoring and reporting a wide variety of physical conditions and diseases for medical and healthcare purposes for individualized medicine and healthcareACTIVE—
035Administering pharmacy reimbursement programs and services; Administration of patient reimbursement programs; billing; compiling of information into computer databases; management and compilation of computerized databases; medical referrals; physician referrals; medical billing support services; providing an internet-based database of patient medical information designed to facilitate sharing and maintenance of patient medical information between and amongst the patient, insurers and healthcare professionals providing services to the patientACTIVE—
036Insurance claims processing; pharmaceutical benefit management services; pharmacy benefit management services; medical laboratory benefit management services; insurance services, namely, eligibility review and verification provided via an internet-based system for confirming patient identity, eligibility and authorization for health insurance or medicare/medicaid servicesACTIVE—
039Biomedical services, namely, electronic storage of medical data; biomedical services, namely, the storage of human cells for medical use; consulting services in the field of air medical operations in the nature of air medical transport; medical transport services; transportation of medical waste and special wasteACTIVE—
042Scientific research services in the field of blood analysis; blood analysis services; chemical laboratories; biological research; biomedical research; laboratory research in the field of chemistry, biochemistry, biology, health and medicine; laboratory services, namely, pigment and color analysis; laboratory services, namely, imaging core lab services; medical laboratories; rental of laboratory apparatus and instruments; scientific laboratory servicesACTIVE—
044Providing information in the field of pet health; pet hospital services; veterinary special services, namely, medical diagnostic and health care management services and emergency and trauma services for animalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 6, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 6, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 15, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 14, 2016EX4GSOU EXTENSION 4 GRANTED—
Jun 30, 2016EXT4SOU EXTENSION 4 FILED—
Jun 30, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 22, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 21, 2016EX3GSOU EXTENSION 3 GRANTED—
Jan 5, 2016EXT3SOU EXTENSION 3 FILED—
Jan 5, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 22, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 21, 2015EX2GSOU EXTENSION 2 GRANTED—
Jul 21, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 14, 2015EXT2SOU EXTENSION 2 FILED—
Jul 14, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 27, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 26, 2015EX1GSOU EXTENSION 1 GRANTED—
Feb 26, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 9, 2015EXT1SOU EXTENSION 1 FILED—
Jan 9, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 6, 2015CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 6, 2015COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 29, 2014NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 3, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 3, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 14, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 25, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 24, 2014ALIEASSIGNED TO LIE—
Apr 2, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 12, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Mar 12, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 12, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 12, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 19, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 18, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 18, 2014ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 16, 2013GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 16, 2013GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 16, 2013CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 27, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 26, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 26, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 26, 2013CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 26, 2013COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 26, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 26, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 26, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2013DOCKASSIGNED TO EXAMINER—
Sep 28, 2012MPMKNOTICE OF PSEUDO MARK MAILED—
Sep 27, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 27, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance